Microbot Medical (MBOT) EBIT Margin (2016)
Historic EBIT Margin for Microbot Medical (MBOT) over the last 7 years, with Q3 2016 value amounting to 5737.96%.
- Microbot Medical's EBIT Margin rose 212345800.0% to 5737.96% in Q3 2016 from the same period last year, while for Sep 2016 it was 25453.42%, marking a year-over-year decrease of 215457100.0%. This contributed to the annual value of 31415.32% for FY2015, which is N/A changed from last year.
- Microbot Medical's EBIT Margin amounted to 5737.96% in Q3 2016, which was up 212345800.0% from 30309.28% recorded in Q2 2016.
- In the past 5 years, Microbot Medical's EBIT Margin registered a high of 826.99% during Q1 2012, and its lowest value of 42674.62% during Q1 2015.
- Its 5-year average for EBIT Margin is 18705.6%, with a median of 18852.32% in 2013.
- Its EBIT Margin has fluctuated over the past 5 years, first crashed by -282068700bps in 2015, then soared by 212345800bps in 2016.
- Over the past 5 years, Microbot Medical's EBIT Margin (Quarter) stood at 2917.39% in 2012, then plummeted by -582bps to 19907.16% in 2013, then soared by 94bps to 1101.83% in 2014, then tumbled by -2560bps to 29308.7% in 2015, then surged by 80bps to 5737.96% in 2016.
- Its last three reported values are 5737.96% in Q3 2016, 30309.28% for Q2 2016, and 42366.93% during Q1 2016.